Evidence map›Paper›PMID 21784298›Full record

SynthesisJournal of the American Academy of Child and Adolescent Psychiatry2011

Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.

Bret R Rutherford, Joel R Sneed, Jane M Tandler, David Rindskopf, Bradley S Peterson, Steven P Roose

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Journal of the American Academy of Child and Adolescent Psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 7 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 7 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcome.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2014
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
    Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Placebo Effects in Psychotherapy: A Framework.Frontiers in psychiatry · 2019
    Review
  18. Article
  19. Article
  20. Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered.The British journal of psychiatry : the journal of mental science · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Bret R RutherfordColumbia University College of Physicians and Surgeons, New York, NY 10032, USA. brr8@columbia.edu
Joel R Sneed
Jane M Tandler
David Rindskopf
Bradley S Peterson
Steven P Roose
Columbia College · CAColumbia University · USNew York State Psychiatric InstituteQueens College, CUNY · USRoyal College of Physicians · GBThe Graduate Center, CUNY · US

Funding

Three Generations at High and Low Risk for Depression Followed LongitudinallyR01MH036197 · NIMH · YALE UNIVERSITY · PI POSNER, JONATHAN E, WEISSMAN, MYRNA M · 1985 to 2020
$15.0M
Placebo Effects in the Treatment of Depression: Cognitive and Neural MechanismsK23MH085236 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI RUTHERFORD, BRET R · 2010 to 2014
$883k
Vascular depression: A distinct diagnostic entity?K23MH075006 · NIMH · QUEENS COLLEGE · PI SNEED, JOEL R. · 2006 to 2009
$628k
Vascular Depression in African Americans: Phenomenology, treatment, and course ofR21MH087774 · NIMH · QUEENS COLLEGE · PI SINGH, DEEPIKA, SNEED, JOEL R. · 2010 to 2011
$449k
NIMH NIH HHS K23 MH075006NIMH NIH HHS K23 MH085236NIMH NIH HHS MH36197NIMH NIH HHS R01 MH036197NIMH NIH HHS R21 MH087774PHS HHS K02-74677
6 · The paper itself

Abstract

objectiveThis study investigated how study type, mean patient age, and amount of contact with research staff affected response rates to medication and placebo in acute antidepressant trials for pediatric depression.

methodData were extracted from nine open, four active comparator, and 18 placebo-controlled studies of antidepressants for children and adolescents with depressive disorders. A multilevel meta-analysis examined how study characteristics affected response rates to antidepressants and placebo.

resultsThe primary finding was a main effect of study type across patient age and contact amount, such that the odds of medication response were greater in open versus placebo-controlled studies (odds ratio 1.87, 95% confidence interval 1.17-2.99, p = .012) and comparator studies (odds ratio 2.01, 95% confidence interval 1.16-3.48, p = .015) but were not significantly different between comparator and placebo-controlled studies. No significant main effects of patient age or amount of contact with research staff were found for analyses of response rates to medication and placebo. Response to placebo in placebo-controlled trials did significantly increase with the amount of therapeutic contact in older patients (age by contact; odds ratio 1.08, 95% confidence interval 1.01-1.15, p = .038).

conclusionsAlthough patient expectancy strongly influences response rates to medication and placebo in depressed adults, it appears to be less important in the treatment of children and adolescents with depression. Attempts to limit placebo response and improve the efficiency of antidepressant trials for pediatric depression should focus on other causes of placebo response apart from expectancy.

Indexed as

Clinical Trials as TopicPlacebo EffectAdolescentAge FactorsAntidepressive AgentsChildDepressive DisorderHumansLogistic ModelsProfessional-Patient RelationsResearch DesignTreatment OutcomeAntidepressive Agents

Identifiers

PMID21784298
PMCPMC3143372
OpenAlexW2169306695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.